111
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Overexpression of microRNA-340-5p Ameliorates Inflammatory Response and Intracellular Survival of Mycobacterium Tuberculosis in Alveolar Type II Cells

, , , &
Pages 1573-1584 | Published online: 21 Apr 2021

References

  • Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57–72. doi:10.1016/S0140-6736(10)62173-321420161
  • Scott C, Kirking HL, Jeffries C, et al. Tuberculosis trends–United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(10):265–269.25789741
  • Lyon SM, Rossman MD. Pulmonary tuberculosis. Microbiol Spectr. 2017;5(1). doi:10.1128/microbiolspec.TNMI7-0032-2016
  • Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013;368(8):745–755. doi:10.1056/NEJMra120089423425167
  • Williams AE. Functional aspects of animal microRNAs. Cell Mol Life Sci. 2008;65(4):545–562. doi:10.1007/s00018-007-7355-917965831
  • Matsushima K, Isomoto H, Inoue N, et al. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer. 2011;128(2):361–370. doi:10.1002/ijc.2534820333682
  • Yang T, Ge B. miRNAs in immune responses to Mycobacterium tuberculosis infection. Cancer Lett. 2018;431:22–30. doi:10.1016/j.canlet.2018.05.02829803788
  • Zheng ML, Zhou NK, Luo CH. MiRNA-155 and miRNA-132 as potential diagnostic biomarkers for pulmonary tuberculosis: a preliminary study. Microb Pathog. 2016;100:78–83. doi:10.1016/j.micpath.2016.09.00527616444
  • Liu F, Chen J, Wang P, et al. MicroRNA-27a controls the intracellular survival of Mycobacterium tuberculosis by regulating calcium-associated autophagy. Nat Commun. 2018;9(1):4295. doi:10.1038/s41467-018-06836-430327467
  • Ma C, Li Y, Li M, et al. microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infection. Mol Immunol. 2014;62(1):150–158. doi:10.1016/j.molimm.2014.06.01424995397
  • Dorhoi A, Iannaccone M, Farinacci M, et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 2013;123(11):4836–4848. doi:10.1172/JCI6760424084739
  • Li Z, Wong KY, Calin GA, Chng WJ, Chan GC, Chim CS. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact. Clin Epigenetics. 2019;11(1):71. doi:10.1186/s13148-019-0669-231064412
  • Xu Y, Liu Z, Lv L, et al. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8(+) T lymphocytes in human diffuse large B cell lymphoma. J Exp Clin Cancer Res. 2020;39(1):238. doi:10.1186/s13046-020-01752-233168024
  • Zhao L, Zhang X, Wu Z, et al. The downregulation of MicroRNA hsa-miR-340-5p in IAV-Infected A549 cells suppresses viral replication by targeting RIG-I and OAS2. Mol Ther Nucleic Acids. 2019;14:509–519. doi:10.1016/j.omtn.2018.12.01430753994
  • Li X, Huang S, Yu T, et al. MiR-140 modulates the inflammatory responses of Mycobacterium tuberculosis-infected macrophages by targeting TRAF6. J Cell Mol Med. 2019;23(8):5642–5653. doi:10.1111/jcmm.1447231199066
  • Bao Y, Zhu Y, He G, et al. Dexmedetomidine attenuates neuroinflammation In LPS-stimulated BV2 microglia cells through upregulation of miR-340. Drug Des Devel Ther. 2019;13:3465–3475. doi:10.2147/DDDT.S210511
  • Li D, Zhou J, Yang B, Yu Y. microRNA-340-5p inhibits hypoxia/reoxygenation-induced apoptosis and oxidative stress in cardiomyocytes by regulating the Act1/NF-kappaB pathway. J Cell Biochem. 2019;120(9):14618–14627. doi:10.1002/jcb.2872330989715
  • Ou M, Zhang C, Chen J, Zhao S, Cui S, Tu J. Overexpression of MicroRNA-340-5p inhibits pulmonary arterial hypertension induced by APE by downregulating IL-1beta and IL-6. Mol Ther Nucleic Acids. 2020;21:542–554. doi:10.1016/j.omtn.2020.05.02232712318
  • Brodtkorb M, Lingjaerde OC, Huse K, et al. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood. 2014;123(7):1051–1054. doi:10.1182/blood-2013-07-51239224357726
  • Singer-Leshinsky S. Pulmonary tuberculosis: improving diagnosis and management. JAAPA. 2016;29(2):20–25. doi:10.1097/01.JAA.0000476207.96819.a7
  • Iannaccone M, Dorhoi A, Kaufmann SH. Host-directed therapy of tuberculosis: what is in it for microRNA? Expert Opin Ther Targets. 2014;18(5):491–494. doi:10.1517/14728222.2014.89769624641181
  • Kang R, Yao DF, Xu GZ, Zhou YH. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/beta-catenin pathway. Neoplasma. 2020;67(5):1094–1105. doi:10.4149/neo_2020_191022N107332538668
  • Liu D, Lin L, Wang Y, et al. PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway. Oncogenesis. 2020;9(5):58. doi:10.1038/s41389-020-0241-032483111
  • Zhang Z, Liang X, Ren L, et al. LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2. Thorac Cancer. 2020.
  • Tan J, Wang W, Song B, Song Y, Meng Z. Integrative analysis of three novel competing endogenous RNA biomarkers with a prognostic value in lung adenocarcinoma. Biomed Res Int. 2020;2020:2837906. doi:10.1155/2020/283790632802839
  • Xiong Q, Wu S, Wang J, et al. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell Biosci. 2017;7:16. doi:10.1186/s13578-017-0144-828413603
  • Song F, Wei M, Wang J, et al. Hepatitis B virus-regulated growth of liver cancer cells occurs through the microRNA-340-5p-activating transcription factor 7-heat shock protein A member 1B axis. Cancer Sci. 2019;110(5):1633–1643. doi:10.1111/cas.1400430891870
  • Tobin DM, Roca FJ, Oh SF, et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 2012;148(3):434–446. doi:10.1016/j.cell.2011.12.02322304914
  • Scriba TJ, Penn-Nicholson A, Shankar S, et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 2017;13(11):e1006687. doi:10.1371/journal.ppat.100668729145483
  • Djoba Siawaya JF, Chegou NN, van den Heuvel MM, et al. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine. 2009;47(2):132–136. doi:10.1016/j.cyto.2009.05.01619570688
  • Gao L, Pu X, Huang Y, Huang J. MicroRNA-340-5p relieved chronic constriction injury-induced neuropathic pain by targeting Rap1A in rat model. Genes Genomics. 2019;41(6):713–721. doi:10.1007/s13258-019-00802-030848438
  • Liaunardy-Jopeace A, Bryant CE, Gay NJ. The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane. Sci Signal. 2014;7(336):ra70. doi:10.1126/scisignal.200527525074978
  • Wang W, Nag SA, Zhang R. Targeting the NFkappaB signaling pathways for breast cancer prevention and therapy. Curr Med Chem. 2015;22(2):264–289. doi:10.2174/092986732166614110612431525386819